CD274 and colorectal carcinoma: In contrast with the other studies mentioned herein, all patients enrolled in the CRC cohort of KEYNOTE-028 had PD-L1–expressing tumors and response was still limited to a single patient with known MSI-H disease and a BRAFV600E mutation.